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Introduction
Gitelman syndrome is an autosomal recessive disease
characterized by hypokalemic metabolic alkalosis, hypo-
magnesemia, and hypocalciuria
1). This disorder is caused
by mutation in the SLC12A3 gene, which encodes the thia-
zide-sensitive NaCl cotransporter (NCCT). Acquired renal
tubular disorder can be observed in various disease proc-
esses, especially autoimmune diseases
2-10). Acquired Gitel-
man syndrome associated with autoimmune disease is rare
and four cases have been reported in the medical literature
8,
10-12). The mechanism underlying acquired Gitelman syn-
drome associated with autoimmune disease is not clear.
Recently, the presence of circulating auto-antibodies
against NCCT in a patient with autoimmune disease was
reported
8).
In this review article, we will summarize the acquired
Gitelman syndrome associated with autoimmune disease
and discuss the presence of circulating auto-antibodies
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against tubular transporter as a mechanism of acquired re-
nal tubular disorders.
Inherited Gitelman syndrome
Inherited Gitelman syndrome is caused by mutations in
SLC12A3 gene encoding NCCT
13). NCCT is expressed at
the apical membrane of the distal convoluted tubule (DCT),
and loss-of-function mutation in NCCT leads to disruption
of Na
+ and Cl reabsorption in the DCT. Decreased Na
+
reabsorption in the DCT leads to increased sodium delivery
to the collecting tubule resulting in mild volume con-
traction, which activates the renin-angiotensin-aldosterone
system. Aldosterone stimulated secretion of potassium and
hydrogen ions finally results in mild hypokalemic metabol-
ic alkalosis. The mechanisms leading to hypomagnesemia
and hypocalciuria in Gitelman syndrome remain unclear.
Thiazide-induced hypocalciuria and hypomgnesemia have
been explained by passive Ca
2+ reabsorption in proximal
tubules and decreased epithelial Mg
2+ channel TRPM6
14).
Hypomagnesemia and hypocalciuria in Gitelman syndrome
are suggested to have a similar mechanism of thiazide-
induced hypocalciuria and hypomagnesemia because the
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electrolyte disturbances of Gitelman syndrome resemble
those observed with chronic administration of thiazide
diuretics.
Acquired Gitelman syndrome
Acquired renal tubular disorder can be observed in vari-
ous disease processes. Myeloma light chains, amyloidosis
and disorder of vitamin D metabolism have been reported
as causes of acquired renal tubular disorder, but the most
frequent causes of acquired renal tubular disorder are auto-
immune diseases such as systemic lupus erythematosus,
Sjögren’s syndrome, autoimmune thyroiditis and primary
biliary cirrhosis. Table 1 shows acquired renal tubular dis-
order in various autoimmune diseases.
Acquired Gitelman syndrome is rare and five cases have
been reported in the English literature. Four cases were
associated with autoimmune diseases, Sjögren’s syndrome,
and one case with renal transplantation. Table 2 shows the
clinical features of acquired Gitelman syndrome with
Sjögren’s syndrome. Cassatta et al. first described acquired
Gitelman syndrome in a patient with chronic sialoadeni-
tis
10). Unfortunately, this case did not fit the diagnostic cri-
teria for Sjögren’s syndrome. Chen et al. reported on a
patient with acquired Gitelman syndrome with primary
Sjögren’s syndrome, which met the criteria for Sjögren’s
syndrome
11). Schwarz et al. added a case of acquired
Gitelman syndrome with primary Sjögren’s syndrome
12).
Kim et al. reported a patient with acquired Gitelman syn-
drome in primary Sjögren’s syndrome and showed the
presence of circulating auto-antobodies against NCCT
8).
In three of four patients, the leading symptoms were
muscular weakness and cramping of extremities with sicca
syndrome. The diagnosis of acquired Gitelman syndrome
in these cases was based upon the clinical and laboratory
findings. Chen et al. proved the functional defect in NCCT
using thiazide and furosemide testing, with the protocol
reported by Colussi et al., Kim et al. first proved the defect
in NCCT by immunohistochemical staining of NCCT. All
four patients were treated with supplement of potassium
and/or magnesium and/or spironolactone. In three of four
Table 1. Acquired Renal Tubular Disorders in Various Diseases
Acquired renal tubular disorder Underlying disease Defect
Renal tubular acidosis Sjögren’s syndrome
Systemic lupus erythematosus
Primary billiary cirrhosis
Graves’ disease
Renal transplantation
H
+-ATPase
2), AE1
3)
Intercalated cell
4)
Loop of Henle
5)
Cortical collecting duct
6)
Collecting duct
7)
Gitelman syndrome
Sjögren’s syndrome
Renal transplantation
NCCT
8)
Donor NCCT
9)
Bartter syndrome Sjögren’s syndrome NKCC2
10)
AE1, anion exchanger 1; NCCT, thiazide-sensitive NaCl cotransporter; NKCC2, sodium-chloride-potassium cotransporter.
Table 2. Review of Acquired Gitelman Syndrome in Sjögren’s Syndrome
Cassatta et al.
10) Chen et al.
11) Schwarz et al.
12) Kim et al.
8)
Underlying disease
Leading symptom
Genetic analysis of
SLC12A3
Response to
Steroid treatment
Duration of follow-up
Follow-up renal function
(Relapse)
Chronic sialodentinitis
Muscle weakness with
sicca syndrome
Not done
Response
2 year
Stable renal function
(No)
Sjögren’s syndrome
Muscle cramping and
weakness with
sicca syndrome
No mutation of
SLC12A3
Steroid treatment was
not done
2 months
Stable renal function
(No)
Sjögren’s syndrome
Asymptomatic hypokalemia
with sicca syndrome
Not done
Not response
1 year
Stable renal function
(No)
Sjögren’s syndrome
Muscle cramping and
weakness with
sicca syndrome
No mutation of
SLC12A3
Response
6 months
Stable renal function
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patients, serum potassium and magnesium levels were im-
proved and clinical symptoms were attenuated with supple-
ment of potassium and/or magnesium. Steroid treatment
was done in three patients and was effective in two pa-
tients
8, 10). The prognosis of acquire Gitelman syndrome
with primary Sjögren’s syndrome may be good. In three
of four patients, normokalemia was maintained during the
follow-up period. No patient had renal insufficiency or
relapse.
Circulating auto-antibodies and acquired
Gitelman syndrome
Some investigations have been done on the pathoge-
nensis of acquired tubular dysfunction associated with au-
toimmune diseases. Formation of auto-antibodies against
various tubular transporters was suspected and much effort
was given to detect the auto-antibodies. Walsh et al. docu-
mented the immunohistochemical comparison of primary
distal RTA versus acquired distal RTA associated with
Sjögren’s syndrome
3). They performed immunohistochem-
ical staining of renal tissue from a patient with a unique
SLC4A1 mutation, SA613F encoding the anion exchanger
AE1 and tissue from another patient with autoimmiune dis-
tal RTA due to Sjögren’s syndrome. In primary distal RTA,
the expression and location of AE1 and vacuolar H
+-
ATPase (vH
+-ATPase) were altered. However, neither pro-
tein could be detected in acquired distal RTA. These find-
ings indicate that the pathogenesis of primary and acquired
distal RTA is not the same. Bastini et al in other report
detected auto-antibodies against vH
+-ATPase in a patient
with distal RTA in Sjögren’s syndrome
4).
For the pathogenesis of acquire Gitelman syndrome with
primary Sjögren’s syndrome, recently Kim et al. reported
the presence of circulating auto-antobodies against NCCT
8).
They incubated the serum of the patient, who was diag-
nosed as acquired Gitelman syndrome and primary
Sjögren’s syndrome, to renal tissue from a normal mouse.
They compared the staining pattern of the incubated nor-
mal mouse kidney with rabbit polyclonal anti-NCCT
antibody. The incubation of the patient’s serum with nor-
mal mouse kidney tissue showed similar patterns of NCCT
in the DCT compared to the incubation of normal mouse
kidney with the rabbit polyclonal anti-NCCT antibody.
These findings suggest that the presence of the circulating
auto-antibodies in the patient’s serum that were reactive
to normal mouse NCCT.
Summary
Gitelman syndrome is an inherited disease. However,
Gitelman syndrome can be acquired in patients with auto-
immune diseases, especially Sjögren’s syndrome. The pres-
ence of circulating auto-antibodies to NCCT was suggested
as a mechanism of acquired Gitelman syndrome. The lead-
ing symptoms of acquired Gitelman syndrome associated
with Sjögren’s syndrome were muscular weakness and
cramping of extremities with sicca syndrome. Treatment
of acquired Gitelman syndrome was done with supple-
ments of potassium and magnesium and prednisone was
effective in some cases. The prognosis of acquired Gitel-
man syndrome appears to be good. Although, until now,
only 4 cases of acquired Gitelman syndrome associated
with Sjögren’s syndrome were reported, we suspect that
acquired Gitelman syndrome is underreported. Acquired
Gitelman syndrome should be included in the differential
diagnosis of renal involvement in patients with auto-
immune diseases, especially Sjögren’s syndrome.
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